Recombinant Human Erythropoietin Reduces Allogeneic Blood Transfusion Requirements in Patients Undergoing Major Orthopedic Surgery

Haematologia
doi 10.1163/156855900300109198
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Brill

Related search

Blood Transfusion Practices in Major Orthopaedic Surgery

2012English

Evaluation of Effectiveness and Analysis of Goal-Directed Blood Transfusion in Peri-Operation of Major Orthopedic Surgery in Elderly Patients

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

A Trial of Blood Conservation in Cardiovascular Surgery. Effect of Recombinant Human Erythropoietin.

Japanese Journal of Cardiovascular Surgery
1990English

Effect of Human Recombinant Erythropoietin Before Autologous Blood Donation in Gastrointestinal Cancer Surgery.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1999English

Major Hepatectomy Without Allogeneic Blood Transfusion for Hepatocellular Carcinoma

2012English

The Demand Ratio and Effective Agents in Blood Transfusion in Patients Undergoing Prostate Surgery

Pars of Jahrom University of Medical Sciences
2012English

Blood Transfusion Requirements for Patients Undergoing Chemotherapy for Acute Myeloid Leukemia How Much Is Enough?

Haematologica
Hematology
2007English

Effect of Desmopressin on the Amount of Bleeding and Transfusion Requirements in Patients Undergoing Heart Transplant Surgery

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

In Response to “Association of Serum Sodium With Morbidity and Mortality in Hospitalized Patients Undergoing Major Orthopedic Surgery”

Journal of Hospital Medicine
Internal MedicineCare PlanningHealth PolicyFundamentalsSkillsLeadershipManagementDiagnosisMedicineAssessment
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy